Illumina Inc. (ILMN) Stock

Illumina Inc. trades at a P/E ratio of 12.65, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong. Looking ahead, the forward P/E of 22.68 is higher than the current P/E, indicating analysts expect earnings to decline over the next year. The PEG ratio of 0.62 suggests the stock may be undervalued relative to its growth rate.

With a beta of 1.37, Illumina Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 7.01 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Illumina Inc. achieves a profit margin of 29.30%, meaning it retains $29.30 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of 16.80% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 68.10% and ROA at 8.84%, the company generates strong returns on invested capital.

Illumina Inc.'s revenue declined by 4.80% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings decreased by 96.50% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against LABORATORY ANALYTICAL INSTRUMENTS industry averages for proper context.

Illumina Inc. has a market capitalization of $15.82B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 158.30M shares outstanding, the company's ownership is relatively concentrated. As a participant in the LABORATORY ANALYTICAL INSTRUMENTS industry, it competes with other firms in this sector.

Illumina Inc.'s book value per share is $14.66, while the current stock price is $95.12, resulting in a price-to-book (P/B) ratio of 6.49. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

22 analysts cover ILMN with 41% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $112.05 implies 17.8% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:3 Strong Buy, 6 Buy, 10 Hold, 1 Sell, 2 Strong Sell. The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

RSI data is not available for this stock.

MACD and moving average data are not available for this stock.